Huadu Yuchang Decoction in Treating 40 Cases with Ulcerative Colitis

ZHAO Xin-fang; SUN Wei-hua; GAN Xia; LIN Hong; ZHOU Yun

doi:10.13422/j.cnki.syfjx.2014220216

您当前的位置：

首页 >

文章列表页 >

Huadu Yuchang Decoction in Treating 40 Cases with Ulcerative Colitis

更新时间：2024-01-04

- Huadu Yuchang Decoction in Treating 40 Cases with Ulcerative Colitis
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 22, Pages: 216-219(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2014220216
  CLC： R259
- Published：2014
- 稿件说明：
移动端阅览
ZHAO Xin-fang, SUN Wei-hua, GAN Xia, et al. Huadu Yuchang Decoction in Treating 40 Cases with Ulcerative Colitis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(22): 216-219.
DOI：

ZHAO Xin-fang, SUN Wei-hua, GAN Xia, et al. Huadu Yuchang Decoction in Treating 40 Cases with Ulcerative Colitis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(22): 216-219. DOI： 10.13422/j.cnki.syfjx.2014220216.

摘要

目的: 观察化毒愈肠方治疗溃疡性结肠炎(UC)(脾虚湿蕴证)的临床疗效及对肠黏膜核转录因子-κB(NF-κB)和β-防御素(HBD-2)及血清促炎性因子的影响.方法: 将80例UC患者随机按数字法分为对照组和观察组各40例.对照组采用美沙拉嗪肠溶片

吞服勿咀嚼

1 g/次

4次/d.对于中度患者反应不佳者加用泼尼松龙片

10 mg/次

3次/d.观察组在对照组治疗的基础上加服化毒愈肠方

1剂/d

常规水煎煮2次

分早晚2次内服.两组疗程均为8周.进行治疗前后脾虚湿蕴证评分、结肠镜及黏膜组织学评分;采用免疫组化SP法检测肠黏膜NF-κB和HBD-2阳性表达情况

检测治疗前后血清白细胞介数-1(IL-1)、白细胞介数-8(IL-8)及肿瘤坏死因子-α(TNF-α).结果: 治疗后观察组脾虚湿蕴证、结肠镜和肠黏膜组织评分均低于对照组(P<0.01);治疗后观察组肠黏膜NF-κB和HBD-2阳性表达情况均低于对照组(P<0.01);治疗后观察组血清IL-1

IL-8和TNF-α水平均低于对照组(P<0.01);经Ridit分析

观察组临床综合疗效优于对照组(P<0.05);观察组中医证候疗效优于对照组(P<0.05).结论: 化毒愈肠方能改善UC患者的症状

促进溃疡愈合

临床疗效显著

其作用机制可能是通过抑制炎症细胞因子

保护肠道黏膜屏障功能来实现的.

Abstract

Objective:To observe the clinical effect of Huadu Yuchang decoction and its influence on nuclear transcription factor-κB (NF-κB) of intestinal mucosa

human β-defensin-2 (HBD-2) and serous proinflammatory cytokine in treating ulcerative colitis (UC) which belonged to spleen deficiency and dampness syndrome in tradition Chinese medical (TCM) syndromes. Method: Eighty patients with UC were randomly divided into control group (40 cases) and observation group (40 cases) by random number table. Patients in control group took mesalazine enter-coated tablets

to swallow not chew

1 g per time

4 times per day. Moderate patients who were in bad condition added prednisolone tablets

10 mg per time

3 times per day. Based on the treatment of control group

patients in observation group added Huadu Yuchang decoction after decocting for two times

1 dose per day

divided for 2 times. The patients in two groups received 8-week period of treatment. Scores of spleen deficiency and dampness syndrome

colonoscopy and gastric histology were graded before and after treatment. Condition of positive expression of intestinal mucosa NF-κB and HBD-2 were detected by immunohistochemistry SP method

and serous interleukin-1 (IL-1)

interleukin-8 (IL-8) and tumor necrosis factor-α (TNF-α) were detected. Result: After treatment

scores of spleen deficiency and dampness syndrome

colonoscopy and gastric histology in observation group were lower than those in control group (P<0.01). Condition of positive expression of intestinal mucosa NF-κB and HBD-2 in observation group were lower than those in control group (P<0.01). Levels of IL-1

IL-8 and TNF-α were lower than those in control group (P<0.01). According to ridit analysis

the comprehensive curative effect in observation group was superior to that in control group (P<0.05). Syndromes curative effect of TCM syndromes in observation group was better than that in control group (P<0.05). Conclusion: Huadu Yuchang decoction could ameliorate symptoms

improve peptic ulcer healing

and therefore had obvious clinical effect in patients with UC. Its mechanism of action may be related to inhibiting proinflammatory cytokines and protecting barrier function of intestine mucosa.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Curative Effect of Huadu Yuchang Decoction in Treating Ulcerative Colitis by Oral Administration and Enema Method as Well as Influences on Serum IL-22 and IL-23

Nano Oral Colon Targeted Drug Delivery System in Treatment of Ulcerative Colitis： A Review

Comparison of Pharmacokinetics and Tissue Distribution of Free Anthraquinones and Gallic Acid in Mice with Ulcerative Colitis Before and After Processing of Rhei Radix et Rhizoma Carbonisata

Mechanisms of Zhuyuwan in Treating both Intrahepatic Cholestasis and Ulcerative Colitis Based on Homotherapy for Heteropathy

Shaoyaotang Containing Serum Mediates Fas/FasL Pathway to Inhibit Lipopolysaccharide Induced Inflammation and Apoptosis of Caco-2 Cells

Related Author

ZHAO Feiyan

ZHU Wenting

TAN Lin

LUO Wenyu

WANG Xiaoya

BI Xin

WANG Xuecheng

WU Zhenfeng

Related Institution

Jiangxi University of Chinese Medicine

College of Food Science and Technology，Nanchang University

School of Life Sciences，Beijing University of Chinese Medicine

School of Basic Medical Sciences， Chengdu University of Traditional Chinese Medicine（TCM）

School of Basic Medical Sciences， Guangzhou University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰